Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00241 ALI HEALTH
RTNominal down22.050 -0.300 (-1.342%)
Research Report

04/01/2021 10:20

{I-bank focus}Citi lifts HSI target to 30,054 from 28,414

[ET Net News Agency, 4 January 2021] Citi Research lifted its 12-month HSI, HSCEI, and
CSI300 targets to 30,054 (was 28,414, up 6%), 11,609 (was 11,550, up 1%), and 5,525 (was
5,471, up 1%), based on updated estimates for EPS, power demand and M2 growth.
The research house forecast China's GDP growth to accelerate to 16% in 1Q and 8.2% in
2021, mostly driven by private-sector investment and consumption. It recommended that
investors "overweight" private consumption in 2021, avoiding uncertainty from possible
China's policy responses to excessive gearing and fixed asset price appreciation.
Citi's top H-share "buy" names for 2021 are private, consumed-related companies, namely
Tencent (00700), Ali Health (00241), Topsports (06110), China Feihe (06186), Geely Auto
(00175), Kingdee (00268), and ENN Energy (02688).
Citi believes tightening in 2021, if any, will be counter-cyclical, which might be
comparable to that of 2017 considering that China's economy has largely recovered to its
pace prior to the COVID-19 epidemic coupled with solid exports (estimated to rise 1.8% in
2020 and gain 3.5% in 2021). (KL)

Remark: Real time quote last updated: 12/04/2021 12:33
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.